9-Piperazino Levofloxacin is a synthetic byproduct generated during Levofloxacin production, featuring a piperazino group appended to the C-9 position of the quinolone scaffold. This substitution introduces a tetrahydro-piperazine ring connected via a methylene bridge, altering the parent drugโs pharmacophore. Retaining the fluorine at C-6, carboxylic acid at C-3, and pyridine-like nitrogen at C-7, the compound exhibits reduced antimicrobial activity. It functions as an HPLC reference standard for monitoring synthetic process impurities in Levofloxacin APIs.
On RequestC[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2F)N4CCN(CC4)C)C(=O)O
InChI=1S/C18H20FN3O4/c1-10-9-26-17-14(19)13(21-5-3-20(2)4-6-21)7-11-15(17)22(10)8-12(16(11)23)18(24)25/h7-8,10H,3-6,9H2,1-2H3,(H,24,25)/t10-/m0/s1
FHAKLRRIGREDDW-JTQLQIEISA-N